4//SEC Filing
Kuhn Mary J 4
Accession 0001225208-10-020966
CIK 0001405197other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 4:46 PM ET
Size
5.6 KB
Accession
0001225208-10-020966
Insider Transaction Report
Form 4
Kuhn Mary J
Executive VP, Operations
Transactions
- Sale
Common Stock
2010-09-14$23.01/sh−33,000$759,386→ 61,181 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.91 to $23.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]The number of shares reported includes restricted share units representing the right to receive 9,210 shares of the Issuers common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.
Documents
Issuer
Talecris Biotherapeutics Holdings Corp.
CIK 0001405197
Entity typeother
Related Parties
1- filerCIK 0001472044
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 4:46 PM ET
- Size
- 5.6 KB